Establishment of Tohoku Alfreassa's Sendai headquarters and a dual-headquarters structure
First written in FY2023-Q2. 1 of 2 entries say "Achieved", first in FY2023-Q3. Latest entry: FY2023-Q3.
No other company in this theme has enough history to compare yet.
- FY2023-Q3AchievedAnnual report
「In November 2022, consolidated subsidiary 東北アルフレッサ株式会社 established a Sendai head office in Wakabayashi-ku, Sendai, and moved to a dual-head-office structure alongside its existing head office.」
The establishment of the Sendai headquarters and transition to a dual-headquarters structure planned in the previous quarter were completed in November 2022. - FY2023-Q2First statedAnnual report
「In August 2022, consolidated subsidiary 東北アルフレッサ株式会社 (headquartered in Koriyama, Fukushima Prefecture) decided to establish a Sendai headquarters in Wakabayashi Ward, Sendai, in November 2022 and transition to a dual-headquarters structure alongside its existing headquarters. By establishing a headquarters in Sendai, the largest city in the Tohoku region, the company aims to further improve service for customers, strengthen collaboration with business partners including pharmaceutical companies, and contribute more than ever to community healthcare in the Tohoku region.」
東北アルフレッサ decided to establish a Sendai headquarters and transition to a dual-headquarters structure in November 2022. It stated that it would strengthen customer service, collaboration with business partners and its contribution to community healthcare in the Tohoku region from its Sendai base.